Literature DB >> 24786471

MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway.

Li Jiang1, Dongxu He2, Dantong Yang1, Zhen Chen1, Qiongxi Pan1, Aiqin Mao1, Yanfei Cai1, Xiyuan Li1, Hui Xing1, Mei Shi1, Yun Chen1, Iain C Bruce1, Teng Wang3, Linfang Jin3, Xiaowei Qi3, Dong Hua3, Jian Jin4, Xin Ma5.   

Abstract

To investigate the role of microRNAs in the development of chemoresistance and related epithelial-mesenchymal transition (EMT), we examined the effect of miR-489 in adriamycin (ADM)-resistant human breast cancer cells (MCF-7/ADM). MiR-489 was significantly suppressed in MCF-7/ADM cells compared with chemosensitive parental control MCF-7/WT cells. Forced-expression of miR-489 reversed chemoresistance. Furthermore, Smad3 was identified as the target of miR-489 and is highly expressed in MCF-7/ADM cells. Forced expression of miR-489 both inhibited Smad3 expression and Smad3 related EMT properties. Finally, the interactions between Smad3, miR-489 and EMT were confirmed in chemoresistant tumor xenografts and clinical samples, indicating their potential implication for treatment of chemoresistance.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Chemoresistance; Epithelial mesenchymal transition; microRNAs

Mesh:

Substances:

Year:  2014        PMID: 24786471     DOI: 10.1016/j.febslet.2014.04.024

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  44 in total

1.  Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2.

Authors:  Xiaowei Zheng; Siying Chen; Qianting Yang; Jiangxia Cai; Weipeng Zhang; Haisheng You; Jianfeng Xing; Yalin Dong
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis.

Authors:  Lakshmi Arivazhagan; Ganesh Venkatraman; Suresh K Rayala
Journal:  Mol Cell Biol       Date:  2019-03-19       Impact factor: 4.272

Review 3.  Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives.

Authors:  Ravi Kasiappan; Dheeran Rajarajan
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

4.  Notch3 negatively regulates chemoresistance in breast cancers.

Authors:  Xiaoting Gu; Chunxiao Lu; Dongxu He; Yangfan Lu; Jian Jin; Dequan Liu; Xin Ma
Journal:  Tumour Biol       Date:  2016-10-14

5.  MiR-876-5p suppresses epithelial-mesenchymal transition of lung cancer by directly down-regulating bone morphogenetic protein 4.

Authors:  Liang Bao; Lei Lv; Jinping Feng; Yuyu Chen; Xinhua Wang; Shuguang Han; Hongqing Zhao
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

Review 6.  Noncoding RNAs in breast cancer.

Authors:  Pang-Kuo Lo; Benjamin Wolfson; Xipeng Zhou; Nadire Duru; Ramkishore Gernapudi; Qun Zhou
Journal:  Brief Funct Genomics       Date:  2015-12-18       Impact factor: 4.241

7.  Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer.

Authors:  Mithil Soni; Yogin Patel; Eleni Markoutsa; Chunfa Jie; Shou Liu; Peisheng Xu; Hexin Chen
Journal:  Mol Cancer Res       Date:  2018-05-21       Impact factor: 5.852

8.  The role of miRNAs as a predictor of multicentricity in breast cancer.

Authors:  Huseyin Akbulut; Yeliz Emine Ersoy; Ender Coskunpinar; Zuhal Gucin; Seyma Yildiz; Fatma Umit Malya; Burcu Hasturk; Mahmut Muslumanoglu
Journal:  Mol Biol Rep       Date:  2019-02-01       Impact factor: 2.316

9.  Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.

Authors:  H Kang; C Kim; H Lee; J G Rho; J-W Seo; J-W Nam; W K Song; S W Nam; W Kim; E K Lee
Journal:  Cell Death Differ       Date:  2015-09-04       Impact factor: 15.828

10.  MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells.

Authors:  Guanghui Cui; Mingwei Cui; Yuhang Li; Youguang Liang; Weihao Li; Haizhou Guo; Song Zhao
Journal:  Tumour Biol       Date:  2014-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.